In his quest to create the first original, billion-dollar drug from a Chinese laboratory, Chen Li is zeroing in on one of the world’s fastest-growing patient groups: diabetes sufferers in China.
There were 114 million of them at last count, more than double a 2010 estimate. Numbers are surging because of changing diets and lifestyles, and a genetic susceptibility to the metabolic disease. Once the top scientist in China with Swiss drugmaker Roche Holding AG, Chen is developing a new treatment for diabetes, which he says afflicts Chinese when they’re younger and thinner than Caucasians.
Hey, check out all the research scientist jobs. Post your resume today!
